| Literature DB >> 31618973 |
Georgia M Sinclair1,2, Allyson L O'Brien3, Michael Keough4, David P de Souza5, Saravanan Dayalan6, Komal Kanojia7, Konstantinos Kouremenos8, Dedreia L Tull9, Rhys A Coleman10, Oliver A H Jones11, Sara M Long12,13.
Abstract
Environmental pollutants such as heavy metals and fungicides pose a serious threat to waterways worldwide. Toxicological assessment of such contaminants is usually conducted using single compound exposures, as it is challenging to understand the effect of mixtures on biota using standard ecotoxicological methods; whereas complex chemical mixtures are more probable in ecosystems. This study exposed Simplisetia aequisetis (an estuarine annelid) to sublethal concentrations of a metal (zinc) and a fungicide (boscalid), both singly and as a mixture, for two weeks. Metabolomic analysis via gas and liquid chromatography-mass spectrometry was used to measure the stress response(s) of the organism following exposure. A total of 75 metabolites, including compounds contributing to the tricarboxylic acid cycle, the urea cycle, and a number of other pathways, were identified and quantified. The multiplatform approach identified distinct metabolomic responses to each compound that differed depending on whether the substance was presented singly or as a mixture, indicating a possible antagonistic effect. The study demonstrates that metabolomics is able to elucidate the effects and mode of action of contaminants and can identify possible outcomes faster than standard ecotoxicological endpoints, such as growth and reproduction. Metabolomics therefore has a possible future role in biomonitoring and ecosystem health assessments.Entities:
Keywords: annelid; biomonitoring; ecotoxicology; fungicide; metal; mixtures
Year: 2019 PMID: 31618973 PMCID: PMC6835977 DOI: 10.3390/metabo9100229
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
PERMANOVA, multivariate analysis for metabolite changes to treatment as main effect. Pairwise comparison analysis for each treatment.
| Source of Variation | GC–MS Metabolites | LC–MS Metabolites | ||||
|---|---|---|---|---|---|---|
|
| MS | P |
| MS | P | |
| Treatment | 3 | 72.14 | 0.0691 | 3 | 5.69 × 1015 | 0.0006 1 |
| Residual | 10 | 34.973 | 8 | 1.17 × 1015 | ||
|
|
|
|
|
| ||
| Ctl, Bos | 1.0406 | 0.3024 | 1.5462 | 0.2041 | ||
| Mix, Bos | 1.5246 | 0.2004 | 2.4663 | 0.0999 | ||
| Zn, Bos | 1.3158 | 0.1404 | 2.1502 | 0.0994 | ||
| Ctl, Mix | 1.5209 | 0.1722 | 1.8296 | 0.1028 | ||
| Ctl, Zn | 0.7768 | 0.7968 | 1.7654 | 0.1960 | ||
| Zn, Mix | 1.6489 | 0.0301 1 | 4.2502 | 0.0975 | ||
1 Values that had significant differences between treatments (P < 0.05). Ninety-five percent family-wise confidence level. Permutational Multivariate Analysis of Variance Analysis (PERMANOVA).
Figure 1A partial least squares discriminant analysis: separation of identified metabolites from whole annelids (S. aequisetis) across treatment groups, following a GC–MS approach. Cross-validation data can be found in the supplementary material (Figure S1 and Table S3).
Figure 2A partial least squares discriminant analysis: separation of identified metabolites from whole annelids (S. aequisetis) across treatment groups, following an LC–MS approach. Cross-validation data can be found in the supplementary material (Figure S2 and Table S4).
One-way analysis of variance for individual metabolites, measured following exposure to treatments (zinc, boscalid, and mix).
| Metabolite | MS Residual | Treatment | Comparison | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Valine | 0.128 | 0.022 2 | 0.259 | 0.061 | 0.017 2 | 0.843 | 0.409 | 0.821 | |
| Leucine | 0.062 | 0.043 2 | 0.161 | 0.034 2 | 0.103 | 0.837 | 0.999 | 0.873 | |
| Serine | 0.076 | 0.003 2 | 0.003 | 0.008 2 | 0.023 2 | 0.780 | 0.387 | 0.862 | |
| Threonine | 0.187 | 0.003 2 | 0.014 | 0.037 2 | 0.002 2 | 0.816 | 0.780 | 0.260 | |
| Aspartic acid | 0.311 | 0.044 2 | 0.081 | 0.074 | 0.056 | 0.999 | 1.000 | 0.997 | |
| Hydroxyproline | 0.086 | 0.005 2 | 0.009 2 | 0.012 2 | 0.008 2 | 0.957 | 0.995 | 0.992 | |
| Methionine | 0.089 | 0.040 2 | 0.115 | 0.035 2 | 0.452 | 0.938 | 0.660 | 0.296 | |
| Ribose | 1.006 | 0.034 2 | 0.629 | 0.317 | 0.764 | 0.045 2 | 0.988 | 0.052 | |
| Asparagine | 0.178 | 0.006 2 | 0.0132 | 0.013 2 | 0.009 2 | 0.995 | 1.000 | 0.994 | |
| Ornithine | 0.587 | 0.050 2 | 0.136 | 0.053 | 0.076 | 0.076 | 0.997 | 0.994 | |
|
|
|
|
| ||||||
| Aminophenylacetic acid | 0.043 2 | 0.014 2 | 0.983 | 1.000 | 0.024 2 | 0.973 | 0.039 2 | 0.022 2 | |
| Citrulline | 0.053 | 0.046 2 | 0.997 | 0.999 | 0.074 | 0.985 | 0.099 | 0.061 | |
| Epinephrine | 0.116 | 0.046 2 | 0.859 | 0.572 | 0.038 2 | 0.460 | 0.114 | 0.240 | |
| Homoserine | 0.081 | 0.002 2 | 0.009 2 | 0.290 | 0.002 2 | 0.132 | 0.468 | 0.016 2 | |
| Normetanephrine | 0.135 | 0.032 2 | 0.997 | 0.910 | 0.050 2 | 0.833 | 0.038 2 | 0.125 | |
| Ornithine | 0.048 | 0.014 2 | 0.060 | 1.000 | 0.608 | 0.063 | 0.011 2 | 0.589 | |
| Proline | 0.106 | 0.018 2 | 0.257 | 0.260 | 0.011 2 | 1.000 | 0.180 | 0.177 | |
| Serine | 0.059 | 0.042 2 | 0.050 2 | 0.231 | 0.968 | 0.701 | 0.094 | 0.404 | |
| Threonine | 0.083 | 0.002 2 | 0.010 2 | 0.300 | 0.002 2 | 0.138 | 0.473 | 0.017 2 | |
| Tyramine | 0.156 | 0.047 2 | 0.321 | 0.401 | 0.0312 | 0.998 | 0.386 | 0.308 | |
2 Values that had significant differences of metabolite abundance between treatments (P < 0.05). Ninety-five percent family-wise confidence level.
Figure 3Line graphs of metabolites which significantly changed in abundance (p < 0.05) following whole annelid (S. aequisetis) single exposure to zinc, boscalid and to their mixture. (A) Valine; (B) Leucine; (C) Serine; (D) Threonine; (E) Aspartic acid; (F) Hydroxyproline; (G) Methionine; (H) Ribose; (I) Asparagine; and (J) Ornithine. Y axis shows the peak area abundance for each metabolite from the GC-MS analysis.
Figure 4Line graphs of metabolites which significantly changed in abundance (p < 0.05) following whole annelid (S. aequisetis) single exposure to zinc, boscalid and to their mixture using LC-MS data: (A) Aminophenylactic acid; (B) Citrulline; (C) Epinephrine; (D) Homoserine; (E) Normetanephrine; (F) Ornithine; (G) Proline; (H) Serine; (I) Threonine; and (J) Tyramine. Y axis shows the peak area for each metabolite from the LC-MS analysis.